Figure 1
(A) Distribution of IDH1/2 mutations and cIMPACT-NOW 3 markers according to histopathology; (B) Estimated overall survival after fitting Cox model by cIMPACT-NOW 3 signature.
Figure 1 | Scientific Reports
(A) Distribution of IDH1/2 mutations and cIMPACT-NOW 3 markers according to histopathology; (B) Estimated overall survival after fitting Cox model by cIMPACT-NOW 3 signature.
